Table 1

Comparison of prospective population based studies on amyotrophic lateral sclerosis epidemiology

CountryYearsPatients (n)Mean age at diagnosisIncidence rate per 100 000 person-years
MF45–74 yearsPeak incidence>85 years
Rate (95% CI)‡Age classRate (95% CI)Rate (95% CI)
USA (WA)121990–199523557.364.55.6 (3.7 to 7.4)65–748.7 (6.6 to 10.7)6.1 (4.1 to 8.2)¶
Ireland131995–199723164.267.86.3 (4.6 to 7.9)70–7410.9 (7.4 to 14.5)4.8 (0.6 to 9.0)
Scotland141989–1998122665.168.15.5 (5.0 to 6.0)75–7911.3 (9.6 to 13.3)2.3 (0.7 to 5.5)**
Italy, Puglia151998–199913065.464.24.1 (2.6 to 5.7)65–747.7 (5.7 to 9.7)0.0
Italy, Lombardy161998–2002517N/AN/A4.2 (3.4 to 5.1)65–746.8 (5.9 to 7.9)4.7 (3.9 to 5.9)¶
Uruguay172002–20038957.560.53.6 (2.7 to 4.5)N/AN/AN/A
Italy, Piemonte and Valle d'Aosta181995–2004126065.266.25.3 (5.0 to 5.6)70–7410.4 (N/A)1.2 (N/A)**
Ireland192004–200510964.666.15.7 (4.5 to 7.0)65–6911.6 (7.4 to 17.3)0.0
South East England202002–200613860.7†64.6†2.3 (1.8 to 2.7)60–643.4 (2.1 to 4.7)1.2 (0.0 to 2.3)
France, Limousin211997–200720168.167.84.2 (3.4 to 4.9)§75–858.7 (N/A)1.6 (N/A)
The Netherlands*2006–2009121763.065.24.4 (4.1 to 4.7)70–748.5 (7.3 to 9.6)1.5 (0.8 to 2.2)
The Netherlands (capture–recapture)*2006–20091495N/AN/A5.3 (5.0 to 5.6)70–7410.3 (9.0 to 11.6)2.8 (1.8 to 3.8)
  • *Present study. †Median age at diagnosis. ‡Standardised to 1990 US population. §Standardised to 2000 US population. ¶Age class >75 years. **Age class >90 years. N/A, not applicable.